annual cash & cash equivalents:
$2.63B-$544.39M(-17.16%)Summary
- As of today (August 18, 2025), ONC annual cash & cash equivalents is $2.63 billion, with the most recent change of -$544.39 million (-17.16%) on December 31, 2024.
- During the last 3 years, ONC annual cash & cash equivalents has fallen by -$1.75 billion (-39.95%).
- ONC annual cash & cash equivalents is now -39.95% below its all-time high of $4.38 billion, reached on December 1, 2021.
Performance
ONC Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$2.77B+$244.16M(+9.66%)Summary
- As of today (August 18, 2025), ONC quarterly cash & cash equivalents is $2.77 billion, with the most recent change of +$244.16 million (+9.66%) on June 30, 2025.
- Over the past year, ONC quarterly cash & cash equivalents has increased by +$156.10 million (+5.97%).
- ONC quarterly cash & cash equivalents is now -58.12% below its all-time high of $6.62 billion, reached on December 1, 2021.
Performance
ONC quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ONC Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.2% | +6.0% |
| 3 y3 years | -40.0% | -51.4% |
| 5 y5 years | +325.1% | -12.1% |
ONC Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -40.0% | at low | -51.4% | +9.7% |
| 5 y | 5-year | -40.0% | +325.1% | -58.1% | +9.7% |
| alltime | all time | -40.0% | >+9999.0% | -58.1% | >+9999.0% |
ONC Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $2.77B(+9.7%) |
| Mar 2025 | - | $2.53B(-4.1%) |
| Dec 2024 | $2.63B(-17.2%) | $2.64B(-2.7%) |
| Sep 2024 | - | $2.71B(+3.6%) |
| Jun 2024 | - | $2.62B(-6.7%) |
| Mar 2024 | - | $2.80B(-12.0%) |
| Dec 2023 | $3.17B(-18.0%) | $3.19B(0.0%) |
| Sep 2023 | - | $3.19B(-9.6%) |
| Jun 2023 | - | $3.53B(-8.0%) |
| Mar 2023 | - | $3.83B(-15.5%) |
| Dec 2022 | $3.87B(-11.6%) | - |
| Dec 2022 | - | $4.54B(-10.5%) |
| Sep 2022 | - | $5.07B(-11.1%) |
| Jun 2022 | - | $5.70B(-8.7%) |
| Mar 2022 | - | $6.25B(-5.6%) |
| Dec 2021 | $4.38B(+216.6%) | $6.62B(+68.9%) |
| Sep 2021 | - | $3.92B(-10.6%) |
| Jun 2021 | - | $4.38B(-8.9%) |
| Mar 2021 | - | $4.81B(+3.5%) |
| Dec 2020 | $1.38B | $4.65B(-1.4%) |
| Sep 2020 | - | $4.72B(+49.7%) |
| Jun 2020 | - | $3.15B(-6.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $3.37B(+243.3%) |
| Dec 2019 | $618.01M(-13.3%) | $983.03M(-21.1%) |
| Sep 2019 | - | $1.25B(-19.7%) |
| Jun 2019 | - | $1.55B(-4.7%) |
| Mar 2019 | - | $1.63B(-9.3%) |
| Dec 2018 | $712.94M(+197.6%) | $1.80B(-12.3%) |
| Sep 2018 | - | $2.05B(+46.2%) |
| Jun 2018 | - | $1.40B(-5.4%) |
| Mar 2018 | - | $1.48B(+76.9%) |
| Dec 2017 | $239.60M(+173.8%) | $837.52M(+10.6%) |
| Sep 2017 | - | $757.43M(+85.9%) |
| Jun 2017 | - | $407.43M(+24.4%) |
| Mar 2017 | - | $327.48M(-11.1%) |
| Dec 2016 | $87.51M(+389.8%) | $368.17M(+80.8%) |
| Sep 2016 | - | $203.62M(-10.1%) |
| Jun 2016 | - | $226.62M(-8.3%) |
| Mar 2016 | - | $247.23M(+146.0%) |
| Dec 2015 | $17.87M(+28.6%) | $100.49M(-17.2%) |
| Sep 2015 | - | $121.34M(+382.4%) |
| Jun 2015 | - | $25.16M(+81.0%) |
| Dec 2014 | $13.90M(+254.0%) | $13.90M |
| Dec 2013 | $3.93M | - |
FAQ
- What is BeOne Medicines Ltd. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for BeOne Medicines Ltd.?
- What is BeOne Medicines Ltd. annual cash & cash equivalents year-on-year change?
- What is BeOne Medicines Ltd. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for BeOne Medicines Ltd.?
- What is BeOne Medicines Ltd. quarterly cash & cash equivalents year-on-year change?
What is BeOne Medicines Ltd. annual cash & cash equivalents?
The current annual cash & cash equivalents of ONC is $2.63B
What is the all time high annual cash & cash equivalents for BeOne Medicines Ltd.?
BeOne Medicines Ltd. all-time high annual cash & cash equivalents is $4.38B
What is BeOne Medicines Ltd. annual cash & cash equivalents year-on-year change?
Over the past year, ONC annual cash & cash equivalents has changed by -$544.39M (-17.16%)
What is BeOne Medicines Ltd. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of ONC is $2.77B
What is the all time high quarterly cash & cash equivalents for BeOne Medicines Ltd.?
BeOne Medicines Ltd. all-time high quarterly cash & cash equivalents is $6.62B
What is BeOne Medicines Ltd. quarterly cash & cash equivalents year-on-year change?
Over the past year, ONC quarterly cash & cash equivalents has changed by +$156.10M (+5.97%)